FDA staff sees possible J&J psoriasis drug risks (Reuters)

[riky]

FDA staff sees possible J&J psoriasis drug risks
    (Reuters)

 


Reuters - An experimental psoriasis drug from
Johnson & Johnson is effective at relieving symptoms but
extended use may raise the risk of cancer, U.S. drug reviewers
said in documents released on Friday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080613/hl_nm/johnsonandjohnson_psoriasis_dc